BiondVax Pharmaceuticals ... (BVXV)
NASDAQ: BVXV
· Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM
BiondVax Pharmaceuticals Income Statement
Financials in ILS. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 2.75M | 2.75M | 2.75M | 2.75M | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 2.02M | 2.02M | n/a | 2.75M | 2.75M | 2.75M | 2.75M | n/a | n/a | n/a |
Operating Income | -8.71M | -16.9M | -22M | -26.14M | -38.24M | -36.36M | -34.83M | -36.02M | 27.81M | 20.63M |
Interest Income | 8.83M | 10.4M | 11.62M | 6.03M | 1.96M | 393K | 363K | 8.19M | 6.21M | 6.21M |
Pretax Income | -4.13M | -13.22M | -19.12M | -29.27M | -42.07M | -41.21M | -39.98M | -43.32M | 21.04M | -8.95M |
Net Income | 7.78M | -1.31M | -6.88M | -23.23M | -42.07M | -41.21M | -39.98M | -43.32M | 21.04M | -8.95M |
Selling & General & Admin | 7.53M | 10.68M | 14.12M | 19.03M | 21.89M | 24.61M | 23.98M | 20.92M | 22.02M | 19.16M |
Research & Development | 9.24M | 14.28M | 15.94M | 17.8M | 15.84M | 11.24M | 10.34M | 14.54M | 25.1M | 35.15M |
Other Expenses | -8.06M | -8.06M | -8.06M | -11.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.71M | 16.9M | 22M | 26.14M | 38.24M | 36.36M | 34.83M | 36.02M | -27.81M | -20.63M |
Interest Expense | 6.49M | 10.14M | 12.15M | 14.84M | 11.47M | 10.92M | 11.2M | 22.24M | 19.73M | 42.53M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.71M | 16.9M | 22M | 26.14M | 38.24M | 36.36M | 34.83M | 36.02M | -27.81M | -20.63M |
Income Tax Expense | -11.91M | -12.69M | -13.02M | -6.82M | -778K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.38M | 3.24M | 1.94M | 1.87M | 1.87M | 1.86M | 1.64M | 1.43M | 1.43M | 1.33M |
Shares Outstanding (Diluted) | 3.38M | 3.24M | 1.94M | 1.87M | 1.87M | 1.86M | 1.64M | 1.43M | 1.43M | 1.33M |
EPS (Basic) | 1.18 | -4.18 | -8.05 | -12.86 | -24.41 | -26.31 | -27.42 | -32.43 | -12.2 | -42.56 |
EPS (Diluted) | 1.18 | -4.18 | -8.05 | -12.86 | -24.41 | -26.31 | -27.42 | -32.43 | -14.52 | -44.88 |
EBITDA | -5M | -10.84M | -14.87M | -13.06M | -28.61M | -28.47M | -26.97M | -46.73M | 15.13M | 7.94M |
EBIT | -70K | -9.28M | -13.17M | -14.44M | -30.59M | -30.28M | -28.78M | -48.55M | 13.29M | 6.11M |
Depreciation & Amortization | 3.85M | 4.48M | 5.56M | 8.63M | 3.2M | 3.02M | 2.99M | 3M | 3.02M | 3.02M |